Medpace(MEDP) - 2023 Q2 - Earnings Call Presentation

1.38x 1.49x 17.7% 17.6% 1.28x 1.28x 1.23x 1.23x 1.28x 1.25x 17.0% 16.7% 16.6% 16.8% 3Q21 4Q21 1Q22 2Q22 3Q22 4Q22 1Q23 2Q23 3Q21 4Q21 1Q22 2Q22 3Q22 4Q22 1Q23 2Q23 Net New Business Awards ($ in millions) MAKING THE COMPLEX SEAMLESS Q2 2023 – KEY FINANCIAL HIGHLIGHTS A. See the appendix for the non-GAAP reconciliation of the EBITDA calculations. B. Net income per diluted share for 2Q23 and 2Q22 excludes $0.041 million and $0.031 million, respectively, in undistributed earnings allocated to RSAs. Net income p ...